These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 11517194

  • 1. Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation.
    Müller MB, Preil J, Renner U, Zimmermann S, Kresse AE, Stalla GK, Keck ME, Holsboer F, Wurst W.
    Endocrinology; 2001 Sep; 142(9):4150-3. PubMed ID: 11517194
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD, Oitzl MS, Workel JO, de Kloet ER.
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [Abstract] [Full Text] [Related]

  • 7. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
    Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP.
    Nat Genet; 2000 Apr; 24(4):403-9. PubMed ID: 10742107
    [Abstract] [Full Text] [Related]

  • 8. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.
    Kishimoto T, Radulovic J, Radulovic M, Lin CR, Schrick C, Hooshmand F, Hermanson O, Rosenfeld MG, Spiess J.
    Nat Genet; 2000 Apr; 24(4):415-9. PubMed ID: 10742109
    [Abstract] [Full Text] [Related]

  • 9. Differential disinhibition of the neonatal hypothalamic- pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice.
    Schmidt MV, Deussing JM, Oitzl MS, Ohl F, Levine S, Wurst W, Holsboer F, Müller MB, de Kloet ER.
    Eur J Neurosci; 2006 Oct; 24(8):2291-8. PubMed ID: 17042789
    [Abstract] [Full Text] [Related]

  • 10. A single episode of restraint stress regulates central corticotrophin- releasing hormone receptor expression and binding in specific areas of the mouse brain.
    Greetfeld M, Schmidt MV, Ganea K, Sterlemann V, Liebl C, Müller MB.
    J Neuroendocrinol; 2009 May; 21(5):473-80. PubMed ID: 19302188
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.
    Yamamoto M, Ben-Shlomo A, Kameda H, Fukuoka H, Deng N, Ding Y, Melmed S.
    JCI Insight; 2018 Oct 04; 3(19):. PubMed ID: 30282821
    [Abstract] [Full Text] [Related]

  • 14. Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice.
    Yoshida-Hiroi M, Bradbury MJ, Eisenhofer G, Hiroi N, Vale WW, Novotny GE, Hartwig HG, Scherbaum WA, Bornstein SR.
    Mol Psychiatry; 2002 Oct 04; 7(9):967-74. PubMed ID: 12399950
    [Abstract] [Full Text] [Related]

  • 15. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS, Hwang IK, Shin JH, Choi JH, Lee CH, Kim IY, Kim YN, Won MH, Park IS, Seong JK, Yoon YS.
    J Chem Neuroanat; 2010 Oct 04; 40(2):130-9. PubMed ID: 20472052
    [Abstract] [Full Text] [Related]

  • 16. Regulation of the developing hypothalamic-pituitary-adrenal axis in corticotropin releasing hormone receptor 1-deficient mice.
    Schmidt MV, Oitzl MS, Müller MB, Ohl F, Wurst W, Holsboer F, Levine S, De Kloet ER.
    Neuroscience; 2003 Oct 04; 119(2):589-95. PubMed ID: 12770571
    [Abstract] [Full Text] [Related]

  • 17. Blunted HPA axis reactivity reveals glucocorticoid system dysbalance in a mouse model of high anxiety-related behavior.
    Sotnikov S, Wittmann A, Bunck M, Bauer S, Deussing J, Schmidt M, Touma C, Landgraf R, Czibere L.
    Psychoneuroendocrinology; 2014 Oct 04; 48():41-51. PubMed ID: 24995583
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function.
    Karanth S, Linthorst AC, Stalla GK, Barden N, Holsboer F, Reul JM.
    Endocrinology; 1997 Aug 04; 138(8):3476-85. PubMed ID: 9231802
    [Abstract] [Full Text] [Related]

  • 19. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.
    Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, Blanquet V, Steckler T, Holsboer F, Wurst W.
    Nat Genet; 1998 Jun 04; 19(2):162-6. PubMed ID: 9620773
    [Abstract] [Full Text] [Related]

  • 20. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M, Romaní-Pérez M, Outeiriño-Iglesias V, Vigo E, González-Matías LC, Brubaker PL, Mallo F.
    Endocrinology; 2014 Jul 04; 155(7):2511-23. PubMed ID: 24731096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.